Pictet Asset Management
NUVB icon

Pictet Asset Management’s Nuvation Bio NUVB Stock Holding History

Pictet Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Hold
40,984
– – ﹤0.01% 1906
2026
Q1 		$176K Hold
40,984
– – ﹤0.01% 1962
2025
Q4 		$367K Buy
40,984
+20,585
+101% +$128K ﹤0.01% 1603
2025
Q3 		$75.5K Sell
20,399
-26,786
-57% -$73K ﹤0.01% 2006
2025
Q2 		$92K Hold
47,185
– – ﹤0.01% 1952
2025
Q1 		$83K Buy
47,185
+13,514
+40% +$30.8K ﹤0.01% 1957
2024
Q4 		$89.6K Buy
+33,671
New +$86.7K ﹤0.01% 1991
2024
Q3 		– Sell
-17,124
Closed -$50K – 2036
2024
Q2 		$50K Buy
+17,124
New +$52.3K ﹤0.01% 1947

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Pictet Asset Management's NUVB Position: Q2 2026 in Review

Pictet Asset Management held its Nuvation Bio (NUVB) position steady in Q2 2026 at 40,984 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #1906.

Pictet Asset Management first reported a position in NUVB in Q2 2024 and has held it in 8 quarters since. The position peaked at $367K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Pictet Asset Management held 40,984 shares of Nuvation Bio worth $233K as of Q2 2026.
  • Pictet Asset Management left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1906 holding.
  • Pictet Asset Management first reported a position in Nuvation Bio in Q2 2024 and has held it in 8 quarters since.
  • Pictet Asset Management's Nuvation Bio position peaked at $367K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.